Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01661400
Title Anti-Angiogenic Therapy Post Transplant (ASCR) for Relapsed and Refractory Pediatric Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

rhabdomyosarcoma

childhood brain stem glioma

brain glioma

Ewing sarcoma

Ewing sarcoma of bone

extraosseous Ewing sarcoma

Advanced Solid Tumor

nephroblastoma

spinal cord glioma

childhood medulloblastoma

high grade glioma

pediatric ependymoma

retinoblastoma

Therapies

Cyclophosphamide

Thalidomide

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.